2 results
Approved WMOWill not start
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.
Approved WMORecruiting
Primary objectivePhase I: To determine the recommended phase II dose (RP2D) of the combination treatment with nivolumab and entinostat administered to adolescents 12-21 years with progressive, relapsed , refractory high-risk solid tumors and CNS…